Filter posts

#BIF2012 Company Snapshot: Profil Institute for Translational Medicine

For the next Company Snapshot for the BIO Investor Forum, we’ve spoken with one of …

2012 BIO Investor Forum: Presenting Companies Making News

Need a heart valve? Perhaps a bit more cartilage in your knees? Better yet, how …

A Start-Up Model Worthy of Consideration

Biotech LLCs are getting a lot of attention lately, and perhaps rightfully so. The Wall …

#BIF2012 Company Snapshot: ContraFect Corporation

The BIO Investor Forum is fast approaching! Below you’ll find our first Company Snapshot of …

2012 BIO Investor Forum: Looking Ahead to Investment Opportunities

The biggest biotech news out of Washington in recent months was the Jumpstart Our Business …

2012 Fall Event Preview

The 2012 BIO International Convention, the global event for biotechnology, held at the Boston Convention …

Opportunity or Apocalypse? Prophecies for 2012

On day two of the BIO Investor Forum in San Francisco, Calif., attendees were eager …

Beyond the ABCs of ADCs

The recent FDA approval of Seattle Genetics’ antibody, Adcetris, has cast the spotlight on Antibody …

Resistance is Futile – SuperDrugs for SuperBugs

“MRSA’s kill 100,000 people a year, more than AIDS,” said Mark Leuchetenberger, President and CEO, …

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

Insights in to the molecular and genetic basis of disease are driving new product and …